Third of long COVID patients suffer persistent smell loss, study finds
Smell loss is one of the most prevalent symptoms of long Covid according to a new study from the University of East Anglia. New research published today reveals… read more.
The latest coronavirus developments and scientific research on prevention and treatment.
Smell loss is one of the most prevalent symptoms of long Covid according to a new study from the University of East Anglia. New research published today reveals… read more.
According to a new study published in Nursing Outlook, the journal of the American Academy of Nursing, chronic hospital nurse understaffing and poor hospital work environments that predated the Covid-19 pandemic… read more.
The antiviral drug nirmatrelvir plus ritonavir (Paxlovid) was granted Emergency Use Authorization for treating COVID-19 in December 2021. In clinical trials, the antiviral was associated with an 88%… read more.
Surgical masks are not inferior to N95 masks for stopping the spread of COVID-19, says a study led by McMaster University researchers. The results follow the tracking of… read more.
An award-winning scheme that saw community pharmacists support patients to understand the benefits of being jabbed against Covid-19 and overcome initial hesitancy proved hugely successful, new research by… read more.
A new, large-scale study of more than 20,000 older adults in Canada found that approximately 1 in 8 older adults developed depression for the first time during the… read more.
Children, adolescents and adults have recorded significant new illnesses across 13 distinct diagnosis and symptom complexes after infection with COVID-19, according to a new study published in PLOS Medicine by… read more.
With what some are calling a “tripledemic” of COVID-19, the influenza virus and respiratory syncytial virus, or RSV, soaring in many parts of the country, the holiday season… read more.
Parents may not always turn to health professionals for vaccine advice – and a small subset could even be avoiding the conversation – a new national poll suggests…. read more.
Development of myocarditis after SARS-CoV-2 vaccination is rare but appears to be more frequent among males aged 18-29 and especially after the second mRNA-1273 (Moderna) vaccine. The study… read more.
A study undertaken by management experts at Kingston University’s Business School and Maynooth University in Ireland has shown people in the early stages of their careers were more… read more.
Researchers from the Centenary Institute and the University of Sydney have developed a new nasal vaccination strategy that induces potent lung immunity and protection against the SARS-CoV-2 coronavirus…. read more.
Advertisment